CJC 1295 (without DAC)

CJC 1295 (without DAC) is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to release natural growth hormone, rather than replacing it with synthetic hormone.

It is not a steroid, but a peptide that supports more physiologic, pulse-based growth hormone patterns in collaboration with the body’s existing rhythms.

The peptide exists in two primary forms with distinct pharmacokinetic profiles:

• CJC-1295 with DAC (Drug Affinity Complex): Features an extended half-life of 6–8 days due to albumin binding, allowing for once-weekly dosing. 
 It provides sustained elevation of growth hormone and IGF-1 levels, making it suitable for long-term body composition and wellness programs.
• CJC-1295 without DAC (Modified GRF 1-29): Has a short half-life of approximately 30 minutes, requiring 2–3 daily injections. 
 It promotes more natural, pulsatile growth hormone release and is often stacked with other peptides like Ipamorelin for synergistic effects.

Common reported benefits include increased lean muscle mass, reduced body fat, enhanced workout recovery, and improved sleep quality.

Potential side effects include injection-site reactions, water retention, mild headaches, and temporary shifts in blood sugar.